COVID-19 vaccine scheme for world’s poorest pushes for delivery slowdown
Leaders of the global scheme aiming to get COVID-19 vaccines to the world’s poorest are pushing manufacturers including Pfizer (PFE.N) and Moderna (MRNA.O) to cut or slow deliveries of about half a billion shots so doses are not wasted.
Special Report: U.S. rushed contracts to COVID-19 suppliers with troubled plants
As the Trump administration debated whether to declare COVID-19 a national emergency early last year, a little-known U.S. health office issued a public plea to Big Pharma.
AstraZeneca COVID-19 sales jump as drugmaker navigates vaccine challenges
Second-quarter sales of AstraZeneca’s (AZN.L) COVID-19 vaccine more than tripled to $894 million from the first quarter, but the drugmaker on Thursday again delayed its U.S. application for approval as it gathers more data for submissions.
New York, drug distributors reach $1.18 bln opioid settlement as national deal looms
The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid epidemic, the state’s attorney general said on Tuesday.
Wall Street ends sharply lower as Delta variant sparks new lockdown fears
A surge in Delta variant infections sparked a broad sell-off on Wall Street on Monday as investors feared renewed COVID-19 shutdowns and a protracted economic recovery.
U.S. pharmacies strike first deals with counties over opioids
Pharmacy operators Walgreens Boots Alliance Inc(WBA.O), CVS Health Corp(CVS.N), Rite Aid Corp(RAD.N) and Walmart Inc(WMT.N) have agreed to pay a combined $26 million to settle claims by two New York counties that they fueled an opioid addiction epidemic.
